ArticlePloS one2025
Epidemiological trends of urolithiasis in working-age populations: Findings from the global burden of disease study 1990-2021.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Evaluation of explainable machine learning models for predicting mid-term stone recurrence after percutaneous nephrolithotomy: a retrospective observational cohort study.International urology and nephrology · 2026Observational
- Early urinary decompression and mortality in septic obstructing ureteral stones: a nationwide comparative-effectiveness study.BMC urology · 2026Article
- Risk factors for kidney stone recurrence and early prediction models: a systematic review and meta-analysis.Translational andrology and urology · 2026Article
- Prediction model for additional procedure requirement in flexible ureterorenoscopy using explainable artificial intelligence.Scientific reports · 2026Article
- Efficacy analysis of a flexible-tip vacuum sheath combined with a 7.5F single-use digital ureteroscope in the treatment of upper urinary tract stones.Translational andrology and urology · 2026Article
- Can dynamic changes in preoperative urinary white blood cells and nitrite predict infectious complications after percutaneous nephrolithotomy in culture-positive patients?World journal of urology · 2026Observational
- Article
- [Comparison of extracorporeal shock wave lithotripsy, flexible ureterorenoscopy, and percutaneous nephrolithotomy for lower-pole renal stones : Updated systematic review and meta-analysis].Urologie (Heidelberg, Germany) · 2025Article
- Epidemiology and Management of Kidney Stone Disease - Current Insights.Research and reports in urology · 2025Review
- Holmium Laser Lithotripsy for Urinary Calculi: A Retrospective Analysis from a Tertiary Hospital in Abuja, Nigeria.Nigerian medical journal : journal of the Nigeria Medical AssociationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOne of the most prevalent urinary disorders worldwide, urolithiasis has symptoms and a high rate of recurrence. It has placed a significant strain on the global economy and health care system, particularly among those aged 20-54. Comprehensive research on the global burden and evolving trends of urinary calculi in the 20-54 age range is lacking.
methodsThree important urolithiasis indicators-prevalence, incidence, and Disability-Adjusted Life Years (DALYs)-were used from the Global Burden of Disease (GBD) database between 1990 and 2021 for this study.Point estimates were provided, as well as 95% uncertainty intervals (UIs).. To assess trends in the burden of urolithiasis among the 20-54 age range, we used percentage change and estimated annual percentage change (EAPC). The time trends from 1990 to 2021 were thoroughly examined using joinpoint regression analysis. This method makes it possible to compute the annual percent change (APC) and average annual percent change (AAPC), as well as the 95% Confidence Intervals (CIs)that go with them.
resultsThe number of patients, cases, and DALYs linked to urinary stones among people aged 20-54 has significantly increased worldwide. For example, the number of urolithiasis cases increased by 48%, from 1,576,704 in 1990-2,335,010 in 2021. Comparably, the number of new cases increased by 47%, from 42,272,855 in 1990-62,269,033 in 2021. Between 1990 and 2021, the number of DALYs rose from 218,150-290,210, representing a roughly 33% increase. As of 2021, intermediate sociodemographic index (SDI) regions had the highest DALY rates, while medium-high SDI regions had the highest prevalence and incidence rates among the five SDI regions examined for this time period. Individuals between the ages of 50-54 had the greatest incidence rate within the designated cohort for that year, followed by those between the ages of 45-49 and 40-44. Across all age groups, there were noticeable gender differences, with males showing significantly greater rates than girls.
conclusionsOverall, over the past 32 years, the prevalence of urolithiasis among people aged 20-54 has increased dramatically worldwide, especially in low-SDI nations and among those aged 50-54. With the goal of reducing the social and medical cost and enhancing the working-age population's quality of life and productivity, the study's findings highlight the urgent need for focused intervention techniques to prevent and treat urolithiasis in this age group. For example, in middle - high SDI areas, encourage 3 liters of water and a low - salt diet daily, especially for the over - 50s. In middle SDI areas, enhance primary care diagnostics, like using portable ultrasound. Regular screenings should be set for males in high - risk jobs, such as heat - exposed ones. However, this GBD - based study has limitations like data uncertainty, insufficient local strategies, and lack of trend tracking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.